ILoF - Intelligent Lab On Fiber

iLoF is working to enable a new era of personalized medicine by using AI and photonics to build a cloud-based library of diseases biomarkers and biological profiles. It is providing screening and stratification tools in an affordable, fast, portable way, saving up to 40% of cost and 70% of the time spent screening on clinical trials. Supported by leading institutions like Microsoft Ventures, Mayfield or the Oxford University, iLoF is currently focusing a validated platform technology in one of the biggest epidemics of our times: Alzheimer's, while maintaining ongoing verticals on Digestive Cancer, Stroke and Infectious diseases. Recognized by CB Insights a one of the most promising Digital Health companies in the world and by the Financial Times as a Transformational Business in Healthcare, iLoF has been regularly featured in leading outlets like Tech Crunch, Wired and Sifted and listed as a rising star in AI-Driven Drug Discovery, Health Screening & Data Analytics.